Covidien’s Special Chemicals Unit Off the Market

/by

Covidien put the business up for sale in February 2008 (see IBO 5/15/08). Indian newspaper The Economic Times reported in March that a deal with Ranbaxy Fine Chemicals to buy the business had fallen through.

Dublin, Ireland 9/3/09—Health care products company Covidien has ceased marketing for sale its Specialty Chemicals business, which includes Mallinckrodt Baker, a provider of laboratory chemicals and reagents. The company will reclassify the business as a continuing operation within its Pharmaceuticals segment.

< | >